AML, with disrupted hematopoietic system, is usually hallmarked by oncogenic fusion proteins, majorly centralizing on AML1-ETO, CBFB-MYH11, PML-RARA, and MLL-AF9 (32, 33). The gene discussed is MYH11; the disease is acute myeloid leukemia.